- Home
- JRSH vs AKTX Comparison
JRSH vs AKTX Comparison
Compare JRSH & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JRSH
- AKTX
- Stock Information
- Founded
- JRSH 2016
- AKTX N/A
- Country
- JRSH United States
- AKTX United States
- Employees
- JRSH N/A
- AKTX N/A
- Industry
- JRSH Apparel
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- JRSH Consumer Discretionary
- AKTX Health Care
- Exchange
- JRSH Nasdaq
- AKTX Nasdaq
- Market Cap
- JRSH 42.4M
- AKTX 34.7M
- IPO Year
- JRSH 2018
- AKTX N/A
- Fundamental
- Price
- JRSH $3.45
- AKTX $1.19
- Analyst Decision
- JRSH
- AKTX
- Analyst Count
- JRSH 0
- AKTX 0
- Target Price
- JRSH N/A
- AKTX N/A
- AVG Volume (30 Days)
- JRSH 12.2K
- AKTX 67.9K
- Earning Date
- JRSH 02-06-2025
- AKTX 02-15-2025
- Dividend Yield
- JRSH 5.80%
- AKTX N/A
- EPS Growth
- JRSH N/A
- AKTX N/A
- EPS
- JRSH N/A
- AKTX N/A
- Revenue
- JRSH $130,270,418.00
- AKTX N/A
- Revenue This Year
- JRSH $34.21
- AKTX N/A
- Revenue Next Year
- JRSH $10.31
- AKTX N/A
- P/E Ratio
- JRSH N/A
- AKTX N/A
- Revenue Growth
- JRSH N/A
- AKTX N/A
- 52 Week Low
- JRSH $2.68
- AKTX $0.90
- 52 Week High
- JRSH $3.59
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- JRSH 53.97
- AKTX 47.06
- Support Level
- JRSH $3.25
- AKTX $1.13
- Resistance Level
- JRSH $3.52
- AKTX $1.27
- Average True Range (ATR)
- JRSH 0.10
- AKTX 0.12
- MACD
- JRSH -0.00
- AKTX 0.03
- Stochastic Oscillator
- JRSH 68.97
- AKTX 44.92
About JRSH Jerash Holdings (US) Inc.
Jerash Holdings (US) Inc along with its subsidiaries is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers namely Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, Speedo etc. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).